April 20, 2014 | American biopharmaceutical company OPKO Health has entered into a definitive agreement to acquire Inspiro Medical, an Israeli medical device company developing a new platform to deliver drugs to treat respiratory diseases. Inspiro’s Inspiromatic is a “smart” easy-to-use dry powder inhaler with several advantages over existing devices. Financial details of the transaction were not disclosed.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli Startup Tests Cancer Treatment With Pharma Giant
February 07, 2023

EU Awards $5M To Greenhouse Solar Panel Project
February 07, 2023

Israel Builds Super-Advanced Children’s Hospital
February 07, 2023

Two Thirds Of Hi-Tech Workers In Israel Are Men, Study Finds
February 06, 2023
Facebook comments